In comments to the White House Office of Science and Technology Policy, ITIF's Val Giddings argues there is no relationship between the degree of regulatory scrutiny a biotechnology product receives and the degree of hazard it represents.
Testimony & Filings
November 5, 2015
November 4, 2015
Businesses that slip non-disparagement clauses into their consumer contracts are silencing critical public feedback, argued Rob Atkinson in testimony today before the Senate Commerce Committee.
November 3, 2015
Global free trade in data is under “serious threat” from protectionist policies that are balkanizing the 21st century economy by limiting cross-border data flows, argued ITIF Founder and President Robert D. Atkinson in testimony.
October 13, 2015
ITIF offered comments supporting the Charter-TWC merger, with the belief that the deal presents minimal competitive concerns while offering significant public interest benefits.
August 31, 2015
ITIF filed comments supporting the FCC’s proposals to transition the Lifeline program to support broadband subsidies for low-income consumers.
August 3, 2015
ITIF submitted comments to the Federal Trade Commission on emerging Internet peer-to-peer platforms—often called the “sharing” economy—and the economic activity these platforms facilitate.
July 31, 2015
ITIF wrote a letter in support of the Scale-Up Manufacturing Investment Company Act. One of the biggest challenges in the U.S. innovation system is scaling and commercializing innovations, and this bill is a significant step forward in working to address this.
July 28, 2015
ITIF Recommends Policies to Promote Innovation, Productivity, and Competitiveness Before House Democratic Caucus
Stephen Ezell spoke at a panel convened by House Democratic Whip Steny Hoyer to explore ways to spur creation of high-wage, private-sector jobs.
July 15, 2015
ITIF offered comments supporting a petition for rulemaking to expand the role of administrative law judges to adjudicate small-scale spectrum interference disagreements.
June 18, 2015
ITIF Senior Fellow Val Giddings testified before the House Energy and Commerce Subcommittee on Health on the folly of state labeling initiatives.